NOVARTIS INDIA LTD. - 500672 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Novartis India Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here NOVARTIS INDIA LTD. - 500672 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Apropos the subject matter quoted above, please find enclosed the Voting results of the business transacted at the Annual General Meeting of Novartis India Limited held on August 7, 2020 as required under SEBI Listing Regulations. The Board at its meeting held on August 6, 2020, has authorized Mr. Trivikram Guda, Company Secretary & Compliance Officer of the Company to declare the voting results. NOVARTIS INDIA LTD. - 500672 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Apropos the subject matter quoted above, please find enclosed herewith the copies of the newspaper Notices in 'Financial Express' and 'Navshakti' on August 7, 2020. This is for your information and record. NOVARTIS INDIA LTD. - 500672 - Reg. 34 (1) Annual Report
The 72nd Annual General Meeting of the Company was held on Friday, August 7, 2020 at 11:30 a.m. IST through Video Conferencing ('VC')/Other Audio Visual Means ('OAVM'). The AGM shall be deemed to have been held at the Registered Office of the Company ('said AGM'). In this regard, please find enclosed the Annual Report of the Company for the Financial Year 2019-20 along with the Notice of the said AGM duly considered and adopted by the Members of the Company. This is for your information and record. NOVARTIS INDIA LTD. - 500672 - Shareholder Meeting / Postal Ballot-Outcome of AGM
The 72nd Annual General Meeting of the Company was held on Friday, August 7, 2020 at 11:30 a.m. IST through Video Conferencing ('VC')/Other Audio Visual Means ('OAVM'). The AGM shall be deemed to have been held at the Registered Office of the Company ('said AGM'). In terms of the provisions of the Companies Act, 2013 read with Rules made thereunder and provisions of the SEBI Listing Regulations, the Company had provided E-voting facility to the Members whereby they could cast their votes electronically and the Members present at the AGM who did not cast their vote through E-voting casted their votes through electronic voting system after the conclusion of the meeting. The items forming part of the Notice for the said AGM, were considered by the Members through E-voting and the details of the same are enclosed in the letter attached herewith. This is for your information and records. Novartis India Q1 net profit jumps over 5-fold to Rs 4.39 cr on price cuts
The company had posted a net profit of Rs 79 lakh in the corresponding period of previous fiscal NOVARTIS INDIA LTD. - 500672 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Dear Sirs, Pursuant to the notification issued by the Securities and Exchange Board of India (SEBI) dated July 17, 2020, which may be called as the Securities and Exchange Board of India (Prohibition of Insider Trading) (Amendment) Regulations, 2020, we would like to inform you that the Board of Directors of the Company have approved the amendments to its existing Code. Please find enclosed a copy of the revised Code of the Company. The same is also available on the website of the Company www.novatis.in. NOVARTIS INDIA LTD. - 500672 - Unaudited Financial Results For The Quarter Ended June 19, 2020
Dear Sir/ Madam, Kindly note that the Board of Directors of the Company has in its meeting held today i.e. on Thursday, August 6, 2020 ("said meeting"), inter alia considered and approved the Unaudited Financial Results of the Company for the first quarter ended on June 30, 2020. The said Meeting commenced at 10:00 a.m. and concluded at 3:30 p.m. Further, in terms of the applicable provisions of SEBI Listing Regulations, please find enclosed herewith: a.the Unaudited Financial Results; b.Limited Review Report dated August 6, 2020, issued by the Statutory Auditors of the Company with respect to the Unaudited Financial Results and taken on record by the Board of Directors of the Company. The above is for your information and the same is also available on the Company''s website i.e. www.novartis.in Thanking you NOVARTIS INDIA LTD. - 500672 - Outcome Of The Meeting Of The Board Of Directors Of Novartis India Limited ('The Company') Held On August 6, 2020
Dear Sir/ Madam, Kindly note that the Board of Directors of the Company has in its meeting held today i.e. on Thursday, August 6, 2020 ("said meeting"), inter alia considered and approved the Unaudited Financial Results of the Company for the first quarter ended on June 30, 2020. The said Meeting commenced at 10:00 a.m. and concluded at 3:30 p.m. Further, in terms of the applicable provisions of SEBI Listing Regulations, please find enclosed herewith: a. the Unaudited Financial Results; b. Limited Review Report dated August 6, 2020, issued by the Statutory Auditors of the Company with respect to the Unaudited Financial Results and taken on record by the Board of Directors of the Company. The above is for your information and the same is also available on the Company''s website i.e. www.novartis.in Thanking you NOVARTIS INDIA LTD. - 500672 - Disclosure On Covid-19 Impact On Company Business
Details w.r.t. impact of Covid-19 on Company business is mentioned in the letter enclosed herewith.